OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Conditions
Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer · HER2 Negative Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Trial Site, Tucson, Arizona, United States
Clinical Trial Site, Fountain Valley, California, United States
Clinical Trial Site, Glendale, California, United States
Clinical Trial Site, La Jolla, California, United States
Clinical Trial Site, Los Alamitos, California, United States
Clinical Trial Site, Los Angeles, California, United States
Clinical Trial Site, Whittier, California, United States
Clinical Trial Site, Aurora, Colorado, United States
Clinical Trial Site, Denver, Colorado, United States
Clinical Trial Site, Golden, Colorado, United States
Clinical Trial Site, Grand Junction, Colorado, United States
Clinical Trial Site, Danbury, Connecticut, United States
Clinical Trial Site, Newark, Delaware, United States
Clinical Trials Site, Jacksonville, Florida, United States
Clinical Trial Site, Margate, Florida, United States
Clinical Trial Site, Orlando, Florida, United States
Clinical Trial Site, Plantation, Florida, United States
Clinical Trial Site, Tamarac, Florida, United States
Clinical Trial Site, Atlanta, Georgia, United States
Clinical Trial Site, Chicago, Illinois, United States
Clinical Trial Site, Chicago, Illinois, United States
Clinical Trial Site, Urbana, Illinois, United States
Clinical Trial Site, Baton Rouge, Louisiana, United States
Clinical Trial Site, New Orleans, Louisiana, United States
Clinical Trial Site, Baltimore, Maryland, United States
Clinical Trial Site, Boston, Massachusetts, United States
Clinical Trial Site, Detroit, Michigan, United States
Clinical Trial Site, Saint Louis Park, Minnesota, United States
Clinical Trial Site, Woodbury, Minnesota, United States
Clinical Trial Site, Lincoln, Nebraska, United States
Clinical Trial Site, Farmington, New Mexico, United States
Clinical Trial Site, New York, New York, United States
Clinical Trial Site, Port Jefferson Station, New York, United States
Clinical Trial Site, Dayton, Ohio, United States
Clinical Trial Site, Toledo, Ohio, United States
Clinical Trial Site, Portland, Oregon, United States
Clinical Trial Site, Sayre, Pennsylvania, United States
Clinical Trial Site, Nashville, Tennessee, United States
Clinical Trial Site, Nashville, Tennessee, United States
Clinical Trial Site, Nashville, Tennessee, United States
Clinical Trial Site, Dallas, Texas, United States
Clinical Trial Site, Dallas, Texas, United States
Clinical Trial Site, Houston, Texas, United States
Clinical Trial Site, Webster, Texas, United States
Clinical Trial Site, Ogden, Utah, United States
Clinical Trial Site, Spokane, Washington, United States
Clinical Trial Site, Spokane, Washington, United States
Clinical Trial Site, Bahía Blanca, Buenos Aires, Argentina
Clinical Trial Site, Mar del Plata, Buenos Aires, Argentina
Clinical Trial Site, Mar del Plata, Buenos Aires, Argentina
Clinical Trial Site, Córdoba, Córdoba Province, Argentina
Clinical Trial Site, Córdoba, Córdoba Province, Argentina
Clinical Trial Site, San Salvador de Jujuy, Jujuy Province, Argentina
Clinical Trial Site, La Rioja, La Rioja Province, Argentina
Clinical Trial Site, Viedma, Río Negro Province, Argentina
Clinical Trial Site, Rosario, Santa Fe Province, Argentina
Clinical Trial Site, Rosario, Santa Fe Province, Argentina
Clinical Trial Site, San Miguel de Tucumán, Tucumán Province, Argentina
Clinical Trial Site, Buenos Aires, Argentina
Clinical Trial Site, Gosford, New South Wales, Australia
Clinical Trial Site, Westmead, New South Wales, Australia
Clinical Trial Site, Adelaide, South Australia, Australia
Clinical Trial Site, Ballarat Central, Victoria, Australia
Clinical Trial Site, Clayton, Victoria, Australia
Clinical Trial Site, Shepparton, Victoria, Australia
Clinical Trial Site, Nedlands, Western Australia, Australia
Clinical Trial Site, Wels, Austria
Clinical Trial Site, Wiener Neustadt, Austria
Clinical Trial Site, Edegem, Antwerpen, Belgium
Clinical Trial Site, Wilrijk, Antwerpen, Belgium
Clinical Trial Site, Woluwe-Saint-Lambert, Brussels Capital, Belgium
Clinical Trial Site, Charleroi, Hainaut, Belgium
Clinical Trial Site, Leuven, Vlaams Brabant, Belgium
Clinical Trial Site, Salvador, Estado de Bahia, Brazil
Clinical Trial Site, Brasília, Federal District, Brazil
Clinical Trial Site, São Luís, Maranhão, Brazil
Clinical Trial Site, Belo Horizonte, Minas Gerais, Brazil
Clinical Trial Site, Curitiba, Paraná, Brazil
Clinical Trial Site, Recife, Pernambuco, Brazil
Clinical Trial Site, Porto Alegre, Rio Grande do Sul, Brazil
Clinical Trial Site, Porto Alegre, Rio Grande do Sul, Brazil
Clinical Trial Site, Porto Alegre, Rio Grande do Sul, Brazil
Clinical Trial Site, Itajaí, Santa Catarina, Brazil
Clinical Trial Site, Jaú, São Paulo, Brazil
Clinical Trial Site, Sorocaba, São Paulo, Brazil
Clinical Trial Site, Porto Alegre, Brazil
Clinical Trial Site, Rio de Janeiro, Brazil
Clinical Trial Site, Panagyurishte, Pazardzhik, Bulgaria
Clinical Trial Site, Sofia, Sofia-Grad, Bulgaria
Clinical Trial Site, Vratsa, Vratsa, Bulgaria
Clinical Trial Site, Calgary, Alberta, Canada
Clinical Trial Site, London, Ontario, Canada
Clinical Trial Site, Toronto, Ontario, Canada
Clinical Trial Site, Montreal, Quebec, Canada
Clinical Trial Site, Hradec Králové, Hradec Králové Region, Czechia
Clinical Trial Site, Nový Jičín, Moravian-Silesian Region, Czechia
Clinical Trial Site, Olomouc, Olomouc Region, Czechia
Clinical Trial Site, Brno, Czechia
Clinical Trial Site, Prague, Czechia
Clinical Trial Site, Bourg-en-Bresse, Ain, France
Clinical Trial Site, Besançon, Doubs, France
Clinical Trial Site, Nantes, Loire-Atlantique, France
Clinical Trial Site, Nantes, Loire-Atlantique, France
Clinical Trial Site, Compiègne, Oise, France
Clinical Trial Site, Clermont-Ferrand, Puy-de-Dôme, France
Clinical Trial Site, Le Mans, Sarthe, France
Clinical Trial Site, Villejuif, Val-de-Marne, France
Clinical Trial Site, Caen, France
Clinical Trial Site, Montpellier, France
Clinical Trial Site, Paris, France
Clinical Trial Site, Karlsruhe, Baden-Wurttemberg, Germany
Clinical Trial Site, Krefeld, North Rhine-Westphalia, Germany
Clinical Trial Site, Velbert, North Rhine-Westphalia, Germany
Clinical Trial Site, Dresden, Saxony, Germany
Clinical Trial Site, Kiel, Schleswig-Holstein, Germany
Clinical Trial Site, Central, Hong Kong, Hong Kong
Clinical Trial Site, Hong Kong, Hong Kong, Hong Kong
Clinical Trial Site, Kowloon, Hong Kong, Hong Kong
Clinical Trial Site, Hong Kong, Hong Kong
Clinical Trials Site, Hong Kong, Hong Kong
Clinical Trial Site, Pécs, Baranya, Hungary
Clinical Trial Site, Kecskemét, Bács-Kiskun county, Hungary
Clinical Trial Site, Debrecen, Hajdú-Bihar, Hungary
Clinical Trial Site, Avellino, Campania, Italy
Clinical Trial Site, Bologna, Emilia-Romagna, Italy
Clinical Trial Site, Meldola, Emilia-Romagna, Italy
Clinical Trial Site, Modena, Emilia-Romagna, Italy
Clinical Trial Site, Reggio Emilia, Emilia-Romagna, Italy
Clinical Trial Site, Udine, Friuli Venezia Giulia, Italy
Clinical Trial Site, Rome, Lazio, Italy
Clinical Trial Site, Rome, Lazio, Italy
Clinical Trial Site, Milan, Lombardy, Italy
Clinical Trial Site, Rozzano, Lombardy, Italy
Clinical Trial Site, Piacenza, Piacenza, Italy
Clinical Trial Site, Alessandria, Piedmont, Italy
Clinical Trial Site, Aviano, Pordenone, Italy
Clinical Trial Site, Ancona, Italy
Clinical Trial Site, Genova, Italy
Clinical Trial Site, Naples, Italy
Clinical Trial Site, Padova, Italy
Clinical Trial Site, Pavia, Italy
Clinical Trials Site, Sungai Petani, Kedah, Malaysia
Clinical Trial Site, Kota Bharu, Kelantan, Malaysia
Clinical Trial Site, Ipoh, Perak, Malaysia
Clinical Trial Site, George Town, Pulau Pinang, Malaysia
Clinical Trial Site, Putrajaya, Putramya, Malaysia
Clinical Trial Site, Kuching, Sarawak, Malaysia
Clinical Trial Site, Petaling Jaya, Selangor, Malaysia
Clinical Trial Site, Kuala Lumpur, WP, Malaysia
Clinical Trial Site, Guadalajara, Jalisco, Mexico
Clinical Trial Site, Mexico City, Mexico City, Mexico
Clinical Trial Site, Puebla City, Puebla, Mexico
Clinical Trial Site, San Luis Potosí City, San Luis Potosí, Mexico
Clinical Trial Site, Monterrey, Mexico
Clinical Trial Site, Oaxaca City, Mexico
Clinical Trial Site, Sinaloa, Mexico
Clinical Trial Site, Amsterdam, North Holland, Netherlands
Clinical Trial Site, Rotterdam, South Holland, Netherlands
Clinical Trial Site, Lublin, Lublin Voivodeship, Poland
Clinical Trial Site, Lodz, Lódzkie, Poland
Clinical Trial Site, Otwock, Masovian Voivodeship, Poland
Clinical Trial Site, Brzozów, Podkarpackie Voivodeship, Poland
Clinical Trial Site, Rzeszów, Podkarpackie Voivodeship, Poland
Clinical Trial Site, Gdynia, Pomeranian Voivodeship, Poland
Clinical Trial Site, Gdansk, Poland
Clinical Trial Site, Krakow, Poland
Clinical Trial Site, Krakow, Poland
Clinical Trial Site, Poznan, Poland
Clinical Trial Site, Wroclaw, Poland
Clinical Trial Site, Coimbra, Coimbra District, Portugal
Clinical Trial Site, Lisbon, Lisbon District, Portugal
Clinical Trial Site, Lisbon, Lisbon District, Portugal
Clinical Trial Site, Porto, Porto District, Portugal
Clinical Trial Site, Senhora da Hora, Porto District, Portugal
Clinical Trial Site, Mayagüez, Puerto Rico, Puerto Rico
Clinical Trial Site, Oradea, Bihor County, Romania
Clinical Trial Site, Brasov, Brașov County, Romania
Clinical Trial Site, Bucharest, Bucharest, Romania
Clinical Trial Site, Cluj-Napoca, Cluj, Romania
Clinical Trial Site, Cluj-Napoca, Cluj, Romania
Clinical Trial Site, Craiova, Dolj, Romania
Clinical Trial Site, Iași, Iaşi, Romania
Clinical Trial Site, Timișoara, Timiș County, Romania
Clinical Trial Site, Bucharest, Romania
Clinical Trial Site, Iași, Romania
Clinical Trial Site, Suwon, Gyeonggi-do, South Korea
Clinical Trial Site, Busan, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Suwon, South Korea
Clinical Trial Site, Badajoz, Badajoz, Spain
Clinical Trial Site, Badalona, Barcelona, Spain
Clinical Trial Site, Manresa, Barcelona, Spain
Clinical Trial Site, Girona, Girona, Spain
Clinical Trial Site, León, León, Spain
Clinical Trial Site, Lleida, Lleida, Spain
Clinical Trial Site, Madrid, Madrid, Spain
Clinical Trial Site, Pamplona, Navarre, Spain
Clinical Trial Site, Seville, Sevilla, Spain
Clinical Trial Site, Reus, Tarragona, Spain
Clinical Trial Site, Valencia, Valencia, Spain
Clinical Trial Site, Alicante, Spain
Clinical Trial Site, Barcelona, Spain
Clinical Trial Site, Fuenlabrada, Spain
Clinical Trial Site, Madrid, Spain
Clinical Trial Site, Murcia, Spain
Clinical Trial site, Santa Cruz de Tenerife, Spain
Clinical Trial Site, Santiago de Compostela, Spain
Clinical Trial Site, Changhua, Taiwan
Clinical Trial Site, Kaohsiung City, Taiwan
Clinical Trial Site, Taichung, Taiwan
Clinical Trial Site, Taichung, Taiwan
Clinical Trial Site, Tainan, Taiwan
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Bangkok, Thailand
Clinical Trial Site, Bangkok, Thailand
Clinical Trial Site, Bangkok, Thailand
Clinical Trial Site, Chiang Mai, Thailand
Clinical Trial Site, Samut Sakhon, Thailand
Clinical Trial Site, Songkhla, Thailand
Clinical Trial Site, Leicester, Leicestershire, United Kingdom
Clinical Trial Site, Nottingham, Nottingham, United Kingdom
Clinical Trial Site, Taunton, Somerset, United Kingdom
Clinical Trial Site, Bodelwyddan, United Kingdom
Clinical Trial Site, London, United Kingdom
Study leads
Medical Director, MD
Study Director
Olema Pharmaceuticals, Inc.